Our Manufacturing Facilities
To manufacture Active Pharma Ingredients and Drug Intermediates (KSMs)
| Location | Total Area | Built up Area | Total reaction Volume | Number of Reactors | Number of blocks | |
| Unit 1 | Pashamylaram, Hyderabad |
20,066 Sq. Mtrs | 6,412.56 Sq. Mtrs | 275 KL | 81 | 6 |
| Unit 2 | Choutuppal, Hyderabad | 29,490 Sq. Mtrs | 18,685 Sq. Mtrs | 604 KL | 101 | 4 |
| Unit 3 | Sadasivpet, Hyderabad | 4,24,919 Sq. Mtrs | 18,257 Sq. Mtrs | 150 KL | 35 | 2 |
| TOTAL | 4,74,475 Sq. Mtrs | 43,354.56 Sq. Mtrs | 1029 KL | 217 | 12 |
Our Sites are Equipped with
Reactors from 20 L to 7 KL, ATFDs, RCVDs, VTDs, TDs, FBDs, ANFDs
Production
Our process development and production capabilities in synthetic organic chemistry cover a wide therapeutic range of APIs and Intermediates. Our development expertise is backed by our comprehensive understanding of these processes and a strong R&D support. As a result, we provide you with high-quality APIs at competitive prices, while meeting the most stringent industry standards.
Our capabilities in the field of synthetic organic chemistry include.
Grignard Reaction, Chlorination, Hydrogenation, Oxidation, Friedel-Craft Reaction, Bromination, Sodium Hydride, Nitration, Amination, Esterification and many more.
Our most rigid analytical and physical control methods are utilized to deliver desired quality APIs with stringent demands of regulatory bodies in target countries.
Our R & D experts continually strive to improve our processes so that you can benefit from capabilities in developing technologies to deliver and implement new processes that will enhance our production capabilities help you to maintain competitive edge in the marketplace.
Our experts excel in tailoring physical properties to customer requirements. We specialize in polymorphic forms and other bulk physical properties designed to meet your special formulation needs.
Our significant investment in Process Development generates a steady flow of API compounds, enabling customers to go to market with new pharmaceutical products more quickly. About half of the team is dedicated to improving process efficiency and automation, to help customers reduce costs and remain competitive in the global marketplace.
We always get excited to help our customers stay a leading position in the marketplace. With our substantial ongoing investment in upgrading our plants and systemswe will provide the best in quality APIs and intermediates at most competitive prices.
Our QA Ecosystem
Our well-conceived, rigorously implemented Quality Management Systems(QMS) not only ensures excellent quality but also focus on continual improvements aimed at optimizing processes and adding value into the efforts in production. Processes, systems, operations and decisions are aligned to ensure that the end product is of high quality.
We adopted quality by design (QbD) approach in manufacturing thus clearly identifying source of variability and minimize them. Identifying and eliminating defects, mitigating risks wherever they are likely to impact quality has improved our efficiency phenomenally.
Transparency in all areas of operations and building robust quality culture across the organizations with customer-centric approach helps us to delivery safe and high quality APIs and intermediates.
Our commitment to quality is uncompromising and we demonstrate it by:
- Complying with current GMP standards.
- Conducting regular internal and external audits of our manufacturing sites.
- Undergoing regular inspections by the health authorities and customers.
- Implementing continual quality improvement initiatives according to emerging industry trends.
- Enforcing rigorous end-to-end control. We ensure our suppliers comply with quality regulations and standards through periodic audits of their facilities.
Our high standards mean you get products you can trust.
